financetom
Business
financetom
/
Business
/
Autohome Says Cartech Becomes Controlling Shareholder Upon Completion of Share Transfer; New CEO Named
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Autohome Says Cartech Becomes Controlling Shareholder Upon Completion of Share Transfer; New CEO Named
Aug 27, 2025 4:13 AM

06:53 AM EDT, 08/27/2025 (MT Newswires) -- Autohome ( ATHM ) said Wednesday that the transfer of the company's shares between Yun Chen Capital Cayman and Cartech Holding, a subsidiary of Haier Group, has been completed.

Subsequently, Cartech has become a controlling shareholder of the company with the acquisition of about 200.9 million ordinary shares, equating to a shareholding of about 43%.

Yun Chen has ceased to be the controlling shareholder of the company and now holds about 23.9 million ordinary shares, representing a shareholding of about 5.1%.

The company further said that Song Yang has resigned as chief executive officer of Autohome ( ATHM ) and has assumed the role of senior vice president.

Chi Liu, who currently serves as a member of the board of directors of Haier Group and head of the Cartech Automotive business division, has been appointed as CEO and chairman of the Autohome ( ATHM ) board.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Why Is Small-Cap Alzheimer's-Focused AC Immune Stock Trading Higher On Monday?
Why Is Small-Cap Alzheimer's-Focused AC Immune Stock Trading Higher On Monday?
May 13, 2024
Monday, Takeda Pharmaceutical Company Limited ( TAK ) and AC Immune SA ( ACIU ) announced an exclusive, worldwide option and license agreement for AC Immune’s active immunotherapies targeting toxic forms of amyloid beta (Abeta), including ACI-24.060 for Alzheimer’s disease. ACI-24.060 is an anti-Abeta active immunotherapy candidate designed to induce an antibody response against the toxic forms of Abeta believed to drive plaque formation and Alzheimer’s...
Sanara MedTech Q1 Net Loss Widens, Revenue Increases -- Shares Down
Sanara MedTech Q1 Net Loss Widens, Revenue Increases -- Shares Down
May 13, 2024
01:49 PM EDT, 05/13/2024 (MT Newswires) -- Sanara MedTech ( SMTI ) reported Q1 net loss Monday of $0.21 per diluted share, widening from $0.14 a year earlier. One analyst polled by Capital IQ expected a loss of $0.07. Revenue for the quarter ended March 31 was $18.5 million, up from 15.5 million a year earlier. One analyst surveyed by...
Why MiNK Therapeutics Stock Is Up 11% Monday
Why MiNK Therapeutics Stock Is Up 11% Monday
May 13, 2024
MiNK Therapeutics, Inc. ( INKT ) shares are trading higher Monday after the clinical-stage biopharmaceutical company announced private placement financing of $5.8 million. What Happened: On Monday, MiNK Therapeutics ( INKT ) entered into a stock purchase agreement to sell securities in a private investment in public equity (PIPE) agreement. MiNK said it will sell 4.64 million shares at a price...
--Street Color: Kraft Heinz Reportedly Mulls Sale of Oscar Mayer
--Street Color: Kraft Heinz Reportedly Mulls Sale of Oscar Mayer
May 13, 2024
01:50 PM EDT, 05/13/2024 (MT Newswires) -- (Street Color news is derived from real time discussions with market professionals globally subscribed to the Street Color Premium Chat service on Bloomberg IB Chat and the ICE IM. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.) Price: 36.45, Change: +0.21, Percent...
Copyright 2023-2026 - www.financetom.com All Rights Reserved